You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Cervical Screening

ID: 15-9 Oct 2011
Type of Content: Guidelines & Advice, Clinical
Document Status: In-Review
J. Murphy, E. Kennedy, S. Dunn, M. Fung Kee Fung, D. Gzik, C.M. McLachlin, M. Shier, L. Paszat

Patient Population

Average risk asymptomatic women in Ontario, Canada.

Intended Guideline Users

Family physicians, other primary care providers, and gynecology specialists involved in screening women for cervical cancer and its precursors.

Research Question(s)

In Ontario, in the context of an organized cervical screening program:

  1. What is the optimal primary cervical screening method (i.e., human papillomavirus [HPV] DNA testing and/or cytology testing)?
    In average risk, asymptomatic women:
  2. What is the most appropriate age for the initiation of cervical screening?
  3. What is the optimal interval between cervical screenings?
  4. What is the most appropriate age for the cessation of cervical screening?
pdf download Summary (PDF) (325.82 KB)
pdf download Full Report (PDF) (981.17 KB)

Guideline-Based Clinical Tools